Rescheduling could have an outsized impact on the legal marijuana market in the nation’s capital.
Tag: rescheduling
Senator Thune received an “F” grade from NORML in its 2024 voter guide.
NORML’s Deputy Director Paul Armentano said that he was disappointed but hardly surprised by the DEA’s decision to disproportionately include groups opposed to marijuana policy reform as designated participants. “The fight to end our nation’s outdated and failed cannabis prohibition laws has never been fought on a level playing field,” he said.
“We believe NORML has well earned a seat at the table, and that it is in the public interest for it to be heard.”
“At a time when voters are historically divided, ending America’s failed marijuana policies is one issue that Americans largely agree on.”
Nearly 40 years ago, advocates made the case to the DEA’s own judge that cannabis did not meet the definition of a Schedule I controlled substance. Their case is exponentially stronger now.
The hearing is scheduled to commence on Monday, December 2, 2024.
“Nurses have long known through their own first hand experience working with patients that cannabis holds legitimate therapeutic value. That is why, historically, nurses and nursing groups have been among some of the strongest and most outspoken advocates for changes in marijuana policy.”